Multicenter, placebo-controlled trial of lorcaserin for weight management.

Smith, Steven R., Weissman, Neil J., Anderson, Christen M., Sanchez, Matilde, Chuang, Emil, Stubbe, Scott, Bays, Harold, Shanahan, William R.·2010·New England Journal of Medicine
DOI 10.1056/nejmoa0909809

Cited by (105)

Items 101–105 of 105

  1. Lorcaserin vs. Phentermine among non-surgical and surgical obese patients: Anthropometric, glycemic, lipid, safety and cost outcomes
    Elhag, Wahiba, El Ansari, Walid, Abdulrazzaq, Sama, Elsherif, Mohamed, Mustafa, Isra · 2019 · Annals of Medicine and Surgery
  2. Role of Bupropion Plus Naltrexone for the Management of Obesity
    Booth, Kemper, Clements, Jennifer N. · 2016 · Journal of Pharmacy Technology
  3. Effects of lorcaserin on fat and lean mass loss in obese and overweight patients without and with type 2 diabetes mellitus: the BLOSSOM and BLOOM‐DM studies
    Apovian, C., Palmer, K., Fain, R., Perdomo, C., Rubino, D. · 2016 · Diabetes, Obesity and Metabolism
  4. Effectiveness and persistence of anti-obesity medications (liraglutide 3 mg, lorcaserin, and orlistat) in a real-world primary care setting
    Leventhal-Perek, Sharon, Shani, Michal, Schonmann, Yochai · 2023 · Family Practice
  5. Weight maintenance after discontinuation of GLP-1 therapies
    Moiz, Areesha, Filion, Kristian B., Knäuper, Bärbel, Tsoukas, Michael A., Brazeau, Anne-Sophie, Zolotarova, Tetiana, Lelièvre, Audrey, Eisenberg, Mark J. · 2026 · EClinicalMedicine